Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to 0.36.

  • Fortress Biotech's Equity Ratio rose 45849.8% to 0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36, marking a year-over-year increase of 45849.8%. This contributed to the annual value of 0.16 for FY2024, which is 1715.2% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Equity Ratio is 0.36, which was up 45849.8% from 0.27 recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Equity Ratio registered a high of 0.62 during Q1 2021, and its lowest value of 0.1 during Q3 2024.
  • For the 5-year period, Fortress Biotech's Equity Ratio averaged around 0.23, with its median value being 0.18 (2025).
  • Per our database at Business Quant, Fortress Biotech's Equity Ratio tumbled by 13181.89% in 2024 and then skyrocketed by 86293.26% in 2025.
  • Quarter analysis of 5 years shows Fortress Biotech's Equity Ratio stood at 0.57 in 2021, then crashed by 70.16% to 0.17 in 2022, then fell by 20.83% to 0.13 in 2023, then grew by 17.15% to 0.16 in 2024, then skyrocketed by 127.93% to 0.36 in 2025.
  • Its Equity Ratio stands at 0.36 for Q3 2025, versus 0.27 for Q2 2025 and 0.18 for Q1 2025.